|
Novel New Device Diagnoses Irregular Heartbeat: Small Stick-On Device Monitors Heart Rhythm for Weeks
This story is from the category Health
Date posted: 17/05/2012 A study conducted at Scripps Health has found that a novel new heart monitoring device helped emergency room patients avoid unnecessary follow-up care. Scripps Health electrophysiologist Steven Higgins, MD, recently presented findings of the study, titled "Prevalence of Arrhythmias in Emergency Department Patients Discharged Using a Novel Ambulatory Cardiac Monitor," at the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston. The study focused on the use of Zio Patch, a single-use ambulatory cardiac monitor that looks similar to a 2- by 5-inch adhesive bandage and sticks to a patient's chest. The device can continuously monitor their heart rhythm for up to 14 days. "The availability of this new heart monitor is exciting as it improves patient care. The patch is applied and when recording is done, the patient simply drops it in the envelope and returns it through the mail -- it's like the Netflix of heart care," said Dr. Higgins, chairman of the department of cardiology at Scripps Memorial Hospital La Jolla and a lead investigator. "Because they are infrequent, heart rhythm problems are often difficult to diagnose, even though they can be quite serious. The Zio Patch is a new digital advance that will allow us to better diagnose challenging cases so we can provide our patients the best care." Scripps Memorial Hospital La Jolla was the only hospital in Southern California to participate in the study. Other study locations included Stanford Hospital and Scott & White Memorial Hospital in Temple, Texas. The study followed 285 patients who had presented to emergency departments across the country with symptoms possibly related to arrhythmias, such as fainting, palpitations, dizziness and others. Patients received the unencumbering, wire-free Zio Patch prior to being discharged from the emergency room and were instructed to wear the patch until it no longer adhered to their skin -- up to 14 days duration. Devices were mailed back to iRhythm Technologies, Inc., the Zio Patch's developer and service provider, using a pre-paid postage envelope, for analysis and reporting of results to the patient's physician. The researchers found that 59 percent of the symptomatic patients who presented to the emergency rooms did not have arrhythmia and may not require any further work-up. "Thus, the new device has the potential to save the health care system millions of dollars," said Higgins. "We were also surprised to learn that there was 100 percent compliance by the patient with the process, which is an amazing finding for an emergency department study." See the full Story via external site: www.sciencedaily.com Most recent stories in this category (Health): 14/06/2013: Biochip Lab Breakthrough Allows Fast, Reliable Pathogen Identification |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
